Annie Yang Weaver

Person

San Mateo, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 11,753,466
- Issue date Sep 12, 2023
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...
- Patent number 11,267,896
- Issue date Mar 8, 2022
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 10,745,481
- Issue date Aug 18, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 10,577,420
- Issue date Mar 3, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that bind activatable antibodies and methods of use thereof
- Patent number 10,568,977
- Issue date Feb 25, 2020
- CytomX Therapeutics, Inc.
- Luc Roland Desnoyers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and metho...
- Patent number 10,233,244
- Issue date Mar 19, 2019
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...
- Patent number 10,179,817
- Issue date Jan 15, 2019
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that bind activatable antibodies and methods of use thereof
- Patent number 9,737,623
- Issue date Aug 22, 2017
- CytomX Therapeutics, Inc.
- Luc Roland Desnoyers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
GENETICALLY ENGINEERED ANTI-CD19 CAR-T CELLS FOR USE IN TREATING B-...
- Publication number 20240115703
- Publication date Apr 11, 2024
- CRISPR Therapeutics AG
- Ziliang LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...
- Publication number 20240076374
- Publication date Mar 7, 2024
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENETICALLY ENGINEERED T CELLS EXPRESSING BCMA-SPECIFIC CHIMERIC AN...
- Publication number 20230220059
- Publication date Jul 13, 2023
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...
- Publication number 20220306759
- Publication date Sep 29, 2022
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER TREATMENT USING CD38 INHIBITOR AND/OR LENALIDOMIDE AND T-CEL...
- Publication number 20220202859
- Publication date Jun 30, 2022
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20220023439
- Publication date Jan 27, 2022
- CytomX Therapeutics, Inc.
- Lori CARMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20210100913
- Publication date Apr 8, 2021
- CytomX Therapeutics, Inc.
- LORI CARMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...
- Publication number 20200291113
- Publication date Sep 17, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHO...
- Publication number 20190309072
- Publication date Oct 10, 2019
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...
- Publication number 20190202927
- Publication date Jul 4, 2019
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20190117789
- Publication date Apr 25, 2019
- CytomX Therapeutics, Inc.
- LORI CARMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT BIND ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20170326260
- Publication date Nov 16, 2017
- CytomX Therapeutics, Inc.
- Luc Roland Desnoyers
- G01 - MEASURING TESTING
Information Patent Application
ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...
- Publication number 20160355587
- Publication date Dec 8, 2016
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHO...
- Publication number 20160355592
- Publication date Dec 8, 2016
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...
- Publication number 20160355599
- Publication date Dec 8, 2016
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies that Bind Activatable Antibodies and Methods of Use Thereof
- Publication number 20150157748
- Publication date Jun 11, 2015
- CytomX Therapeutics, Inc.
- Luc Roland Desnoyers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Annie Yang Weaver

Person

Patents Grantslast 30 patents

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Antibodies that bind activatable antibodies and methods of use thereof

Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and metho...

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...

Antibodies that bind activatable antibodies and methods of use thereof

Patents Applicationslast 30 patents

GENETICALLY ENGINEERED ANTI-CD19 CAR-T CELLS FOR USE IN TREATING B-...

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...

GENETICALLY ENGINEERED T CELLS EXPRESSING BCMA-SPECIFIC CHIMERIC AN...

ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...

CANCER TREATMENT USING CD38 INHIBITOR AND/OR LENALIDOMIDE AND T-CEL...

ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF

ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...

ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHO...

ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...

ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES THAT BIND ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...

ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHO...

ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...

Antibodies that Bind Activatable Antibodies and Methods of Use Thereof